Sleszynski S L, Kelso A F
Department of Surgery, Chicago-College of Osteopathic Medicine of Midwestern University (CCOM), Ill.
J Am Osteopath Assoc. 1993 Aug;93(8):834-8, 843-5.
Atelectasis is a preventable complication that often occurs after upper abdominal surgery. In our 1-year randomized, researcher-blinded trial, low-risk cholecystectomy patients were subjected to either the thoracic lymphatic pump (n = 21) or incentive spirometry (n = 21) to prevent atelectasis. The treatment groups were equal with respect to risk factors for atelectasis and deviation of preoperative respiratory parameters (forced vital capacity [FVC] and forced expiratory volume in one second [FEV1]) from the predicted values. Atelectasis occurred in 2 (5%) of 21 patients regardless of whether incentive spirometry or thoracic lymphatic pump treatment was used. Study patients treated with the thoracic lymphatic pump technique had an earlier recovery and quicker return toward preoperative values for FVC and FEV1 than patients treated with incentive spirometry.
肺不张是一种可预防的并发症,常发生在上腹部手术后。在我们为期1年的随机、研究者盲法试验中,低风险胆囊切除术患者接受胸段淋巴泵治疗(n = 21)或激励肺活量测定法(n = 21)以预防肺不张。治疗组在肺不张的危险因素以及术前呼吸参数(用力肺活量[FVC]和一秒用力呼气量[FEV1])与预测值的偏差方面是相等的。无论使用激励肺活量测定法还是胸段淋巴泵治疗,21例患者中有2例(5%)发生了肺不张。与接受激励肺活量测定法治疗的患者相比,接受胸段淋巴泵技术治疗的研究患者恢复更早,FVC和FEV1更快恢复到术前值。